Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer
- 17 February 2015
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 33 (4), 1985-1993
- https://doi.org/10.3892/or.2015.3810
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 22 references indexed in Scilit:
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell CharacteristicsJNCI Journal of the National Cancer Institute, 2010
- Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trendsClinical Therapeutics, 2009
- Anthracycline Extravasation: A Comprehensive Review of Experimental and Clinical TreatmentsTumori Journal, 2009
- Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer: Intrinsic and AcquiredSeminars in Oncology, 2008
- Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of EpirubicinThe Oncologist, 2005
- Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide MicroarraysClinical Cancer Research, 2004
- Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- Development of Multidrug-Resistance Convertors: Sense or Nonsense?Investigational New Drugs, 2000
- Anthracycline resistance in breast cancer: Clinical applications of current knowledgeEuropean Journal of Cancer, 1995